NDC 64406-008-01
TYSABRI 300 mg/15mL
natalizumab · INJECTION
TYSABRI is a injection containing natalizumab at a strength of 300 mg/15mL. Manufactured by Biogen Inc..
Key Facts
- Brand Name
- TYSABRI
- Generic Name
- natalizumab
- NDC Code (Package)
64406-008-01- NDC Code (Product)
64406-008- Manufacturer
- Biogen Inc.
- Strength
- 300 mg/15mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125104
- Drug Class
- Integrin Receptor Antagonist [EPC]
- Marketing Start
- 11/23/2004
Recall History
No Recall HistoryView Full Drug Page
TYSABRI — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.